Trials / Completed
CompletedNCT00002336
The Safety and Effectiveness of Clarithromycin in the Prevention of Mycobacterium Avium Complex (MAC) Infection in HIV-Infected Patients
A Prospective, Randomized, Double-Blind, Multicenter, Placebo-Controlled Study of the Safety and Efficacy of Clarithromycin for the Prevention of Disseminated Mycobacterium Avium Complex (MAC) Infection in HIV-Infected Patients With CD4 Counts <= 100 Cells/mm3
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Abbott · Industry
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
To determine whether clarithromycin is safe and effective in preventing disseminated Mycobacterium avium Complex in HIV-infected patients with CD4 counts \<= 100 cells/mm3.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Clarithromycin |
Timeline
- Start date
- 1992-11-01
- Primary completion
- 1994-11-01
- Completion
- 1994-11-01
- First posted
- 2001-08-31
- Last updated
- 2015-01-16
Locations
22 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00002336. Inclusion in this directory is not an endorsement.